Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes

Pancreatic islet cells produce insulin, a hormone that allows cells in the body to absorb glucose from the blood.

| Nov 30, 2009

Many autoimmune diseases, such as lupus erythematosis and type 1 diabetes, are caused by autoantibodies. An autoantibody is an antibody (a protein) produced by the immune system of an individual, which is directed against a different protein of the the same individual.

An antibody is typically produced in response to a foreign protein in the body, for example, an infectious organism.  The immune system is usually able to recognize and ignore the body's own cells and not produce antibodies against them.  At times, however, the immune system fails to recognize a protein in the body as "self" and produces autoantibodies which attack the protein.  This can lead to tissue or organ inflammation and damage. 

There is limited information in the scientific literature concerning the predictability of type 1 diabetes based on specific types of pancreatic islet autoantibodies, either alone or in combination. Pancreatic islet cells produce insulin, a hormone that allows cells in the body to absorb glucose from the blood.

A study published in the December 2009 issue of Diabetes Care attempted to determine which pancreatic islet autoantibodies, or what combination of autoantibodies, best predict type 1 diabetes.  Subjects were taken from the Diabetes Prevention Trial-Type 1, who were previously screened for islet cell autoantibodies (ICAs).

Autoantibodies to glutamate decarboxylase (GAD65), insulinoma-associated antigen-2 (ICA512), and insulin (micro-IAA [mIAA]) were measured in participants of the study.  The participants were then followed for the occurrence of type 1 diabetes. As it turns out, autoantibody number was highly predictive of type 1 diabetes.  Single autoantibodies ICA, GAD65, and ICA512 were all similarly predictive of type 1 diabetes. However, no subjects with mIAA as single autoantibodies developed type 1 diabetes.

The data, examined by corresponding author Jay M. Sosenko in the Division of Endocrinology, University of Miami, Miami, Florida, and colleagues, revealed that that the number of autoantibodies is highly predictive of type 1 diabetes. However, mIAA is less predictive of type 1 diabetes than other autoantibodies. The authors concluded that autoantibody number, and the type of autoantibody must be carefully considered in planning future prevention trials for type 1 diabetes.

This information about the process of developing the autoimmune disease diabetes moves us closer to the point that we can predict and prevent it from occurring -closer to a cure.

Diabetes Care December 2009

diabetesjournals.org

Click Here To View Or Post Comments

Categories: Diabetes, Diabetes, Insulin, Islet & Pancreas Transplant, Research, Type 1 Issues


Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • What's on the Horizon with Diabetes Research and Therapy
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated
Print | Email | Share | Comments (4)

You May Also Be Interested In...


Comments

Posted by Anonymous on 3 December 2009

Interesting read. This is however old information. A friend of mine just lost his third toe from Diabetes. So when will the CURE be available ???? No one seems to know....

Posted by ndocroth on 3 December 2009

When will we start including HLA-DQ2, HLA-DQ8 and other antigens in this kind of research?

With the link between tye 1 diabetes and celiac disease already confirmed, it may be time to look at the cause/trigger of celiac disease - the opioid-exorphine carrying gluten and casein - with regards to their impact on insulin production or control (e.g. via them causing duodenal imflammation).

Rivkah Roth DO DNM® author of At Risk? Avoid Diabetes by Recognizing Early Risk - A Natural Medicine View, and the DIABETES-Series Little Books.

Posted by Anonymous on 3 December 2009

the last line ... "closer to a cure" doesn't sound right. should just say "closer to prevention" and leave it at that. Identifying the predictors of new cases is great for those folks, but I already have type 1 and this does not "cure" or reverse my existing disease.

Posted by Anonymous on 4 December 2009

Thank you Diabetes Health for finally running an article regarding Type 1 diabetes. It feels like all efforts are going to Type 2 and we have been left behind. It will be interesting to see if prevention comes into play from this research. Also maybe a cure!!


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.